Autoproteolytic Fragments Are Intermediates in the Oligomerization/Aggregation of the Parkinson's Disease Protein Alpha‐Synuclein as Revealed by Ion Mobility Mass Spectrometry

No abstract is available for this paper.

• Publication year

  2011

• Venue

  ChemBioChem

• Publication date

  2011-12-16

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1002/cbic.201100569PMID 22162214PMCID PMC3461308
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid-like aggregates sequester numerous metastable proteins with essential cellular functions.

  2011cited by this paper
• Ion Mobility Mass Spectrometry Studies of the Inhibition of Alpha Synuclein Amyloid Fibril Formation by (–)-Epigallocatechin-3-Gallate

  2011cited by this paper
• Ion mobility separation coupled with MS detects two structural states of Alzheimer's disease Aβ1-40 peptide oligomers.

  2011cited by this paper
• Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies.

  2011cited by this paper
• Ion mobility mass spectrometry of proteins and protein assemblies.

  2010cited by this paper
• Ion mobility-mass spectrometry reveals a conformational conversion from random assembly to beta-sheet in amyloid fibril formation

  2010cited by this paper
• 1 Supplementary data for : Ion Mobility Separation coupled with MS detects two structural states of Alzheimer ’ s disease Aβ 1-40 peptide oligomers

  2010cited by this paper
• On-line bioaffinity-electrospray mass spectrometry for simultaneous detection, identification, and quantification of protein-ligand interactions

  2010cited by this paper
• Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors.

  2009cited by this paper
• Role of Synucleins in Alzheimer’s Disease

  2009cited by this paper
• Structural characterization of ß-amyloid oligomer-aggregates by ion mobility mass spectrometry and electron spin resonance spectroscopy

  2009cited by this paper
• Electrospray: from ions in solution to ions in the gas phase, what we know now.

  2009cited by this paper
• Interplay of α-synuclein binding and conformational switching probed by single-molecule fluorescence

  2009cited by this paper
• Binding epitopes and interaction structure of the neuroprotective protease inhibitor cystatin C with beta-amyloid revealed by proteolytic excision mass spectrometry and molecular docking simulation.

  2009cited by this paper
• Functional ubiquitin conjugates with lysine-epsilon-amino-specific linkage by thioether ligation of cysteinyl-ubiquitin peptide building blocks.

  2009cited by this paper
• Spin‐Label EPR on α‐Synuclein Reveals Differences in the Membrane Binding Affinity of the Two Antiparallel Helices

  2008cited by this paper
• Function and structure of inherently disordered proteins.

  2008cited by this paper
• Ion mobility–mass spectrometry analysis of large protein complexes

  2008cited by this paper
• Conformational and noncovalent complexation changes in proteins during electrospray ionization.

  2008cited by this paper
• Ion mobility-mass spectrometry.

  2008cited by this paper
• Ion mobility spectrometry/mass spectrometry snapshots for assessing the molecular compositions of complex polymeric systems.

  2008cited by this paper
• Mass spectrometry reveals modularity and a complete subunit interaction map of the eukaryotic translation factor eIF3

  2008cited by this paper
• Different species of alpha-synuclein oligomers induce calcium influx and seeding.

  2007cited by this paper
• Ion mobility-mass spectrometry reveals long-lived, unfolded intermediates in the dissociation of protein complexes.

  2007cited by this paper
• Mass Spectrometric Approaches for Elucidation of Antigen—Antibody Recognition Structures in Molecular Immunology

  2007cited by this paper
• An investigation of the mobility separation of some peptide and protein ions using a new hybrid quadrupole/travelling wave IMS/oa-ToF instrument

  2007cited by this paper
• Neuropathology, biochemistry, and biophysics of α‐synuclein aggregation

  2007cited by this paper
• Different Species of α-Synuclein Oligomers Induce Calcium Influx and Seeding

  2007cited by this paper
• Copper- and iron-induced differential fibril formation in alpha-synuclein: TEM study.

  2007cited by this paper
• Neuropathology, biochemistry, and biophysics of alpha-synuclein aggregation.

  2007cited by this paper
• Amyloid under the atomic force microscope.

  2006cited by this paper
• Structural differences in Abeta amyloid protofibrils and fibrils mapped by hydrogen exchange--mass spectrometry with on-line proteolytic fragmentation.

  2006cited by this paper
• A synthetic camel anti-lysozyme peptide antibody (peptibody) with flexible loop structure identified by high-resolution affinity mass spectrometry.

  2006cited by this paper
• Identification of rotenone-induced modifications in alpha-synuclein using affinity pull-down and tandem mass spectrometry.

  2006cited by this paper
• Conjugation of chelating agents to proteins and radiolabeling with trivalent metallic isotopes

  2006cited by this paper
• A high-throughput screen for compounds that inhibit aggregation of the Alzheimer's peptide.

  2006cited by this paper
• Lewy bodies.

  2006cited by this paper
• Molecular electron microscopy approaches to elucidating the mechanisms of protein fibrillogenesis.

  2005cited by this paper
• Nosology of Parkinson's disease: looking for the way out of a quagmire.

  2005cited by this paper
• Mechanism of thioflavin T binding to amyloid fibrils.

  2005cited by this paper
• Investigation of intact protein complexes by mass spectrometry.

  2004cited by this paper
• Parkinson's disease α-synuclein mutations exhibit defective axonal transport in cultured neurons

  2004cited by this paper
• "Affinity-proteomics": direct protein identification from biological material using mass spectrometric epitope mapping

  2004cited by this paper
• The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

  2004cited by this paper
• Permeabilization of Lipid Bilayers Is a Common Conformation-dependent Activity of Soluble Amyloid Oligomers in Protein Misfolding Diseases*

  2004cited by this paper
• Quantification of protein-ligand interactions by mass spectrometry, titration, and H/D exchange: PLIMSTEX.

  2003cited by this paper
• Molecular Pathways of Neurodegeneration in Parkinson's Disease

  2003cited by this paper
• AFM and STM study of beta-amyloid aggregation on graphite.

  2003cited by this paper
• AFM and STM study of β-amyloid aggregation on graphite

  2003cited by this paper
• Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T.

  2002cited by this paper
• Therapeutically effective antibodies against amyloid-β peptide target amyloid-β residues 4–10 and inhibit cytotoxicity and fibrillogenesis

  2002cited by this paper
• Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases

  2002cited by this paper
• Therapeutically effective antibodies against amyloid-beta peptide target amyloid-beta residues 4-10 and inhibit cytotoxicity and fibrillogenesis.

  2002cited by this paper
• Alpha-synuclein and neurodegenerative diseases

  2001cited by this paper
• Gas-phase separations of electrosprayed peptide libraries.

  1999cited by this paper
• REVIEW: tau protein pathology in Alzheimer’s disease and related disorders

  1999cited by this paper
• Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

  1998cited by this paper
• AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

  1998cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• Electrospray Mass Spectrometry of Biomacromolecular Complexes with Noncovalent Interactions—New Analytical Perspectives for Supramolecular Chemistry and Molecular Recognition Processes

  1996cited by this paper
• Elektrospray‐Massenspektrometrie von Biomakromoleülkomplexen mit nichtkovalenten Wechselwirkungen – neue analytische Perspektiven für supramolekulare Chemie und molekulare Erkennungsprozesse

  1996cited by this paper
• X‐ray crystallographic and mass spectrometric structure determination and functional characterization of succinylated porin from rhodobacter capsulatus: Implications for ion selectivity and single‐channel conductance

  1996cited by this paper
• Two‐dimensional polyacrylamide gel electrophoresis with immobilized pH gradients in the first dimensin (IPG‐Dalt): The state of the art and the controversy of vertical versus horizontal systems

  1995cited by this paper
• Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease.

  1993cited by this paper
• Molecular epitope identification by limited proteolysis of an immobilized antigen-antibody complex and mass spectrometric peptide mapping.

  1990cited by this paper
• Electrospray ionization for mass spectrometry of large biomolecules.

  1989cited by this paper
• Function and Structure of Inherently Disordered Proteins This Review Comes from a Themed Issue on Proteins Edited Prediction of Non-folding Proteins and Regions Frequency of Disordered Regions Protein Evolution Partitioning Unstructured Proteins and Regions into Groups Involvement of Inherently Diso

  year unknowncited by this paper

• A Mild Protecting-Group Free Strategy for Neoglycoconjugate Synthesis.

  2025cites this paper
• Surface wetting is a key determinant of α-synuclein condensate maturation

  2025cites this paper
• Crosstalk between tau protein autoproteolysis and amyloid fibril formation.

  2024cites this paper
• Advancements in Neurodegenerative Diseases: Pathogenesis and Novel Neurorestorative Interventions

  2024cites this paper
• A Diphenylalanine Based Pentapeptide with Fibrillating Self-Assembling Properties

  2023cites this paper
• Cascade autohydrolysis of Alzheimer's Aβ peptides

  2023cites this paper
• The Utility of Breath Analysis in the Diagnosis and Staging of Parkinson’s Disease

  2022cites this paper
• Using mass spectrometry-based methods to understand amyloid formation and inhibition of alpha-synuclein and amyloid beta.

  2022cites this paper
• α-synuclein enfolds tyrosine hydroxylase and dopamine ß-hydroxylase, potentially reducing dopamine and norepinephrine synthesis

  2022cites this paper
• A Facile Method to Produce N-Terminally Truncated α-Synuclein

  2022influential citation
• Nanoparticle-based colorimetric sensors to detect neurodegenerative disease biomarkers.

  2021cites this paper
• The Diagnostic Potential of Amyloidogenic Proteins

  2021cites this paper
• Electrospray Ionization Ion Mobility Mass Spectrometry

  2021cites this paper
• Vibrio cholerae biofilm scaffolding protein RbmA shows an intrinsic, phosphate‐dependent autoproteolysis activity

  2020cites this paper
• Ion Mobility-Mass Spectrometry

  2019cites this paper
• Exploring the Structural Diversity in Inhibitors of α-Synuclein Amyloidogenic Folding, Aggregation, and Neurotoxicity

  2018cites this paper
• An efficient combination of BEST and NUS methods in multidimensional NMR spectroscopy for high throughput analysis of proteins

  2018cites this paper
• Mass Spectrometric Methodologies for Investigating the Metabolic Signatures of Parkinson's Disease: Current Progress and Future Perspectives.

  2018cites this paper
• Probing early stage aggregates of amyloidogenic proteins using mass spectrometry based methods

  2017influential citation
• Prion-Like Seeding of Misfolded α-Synuclein in the Brains of Dementia with Lewy Body Patients in RT-QUIC

  2017cites this paper
• Implications of peptide assemblies in amyloid diseases.

  2017cites this paper
• Spontaneous cleavage of proteins at serine and threonine is facilitated by zinc

  2016cites this paper
• Der Begriff der Nerventätigkeit in der Pathogenese neurodegenerativer Erkrankungen und ganzheitliche Therapiemöglichkeiten bei M. Parkinson

  2016cites this paper
• Self-Assembled Cyclic d,l-α-Peptides as Generic Conformational Inhibitors of the α-Synuclein Aggregation and Toxicity: In Vitro and Mechanistic Studies.

  2016cites this paper
• Mass spectrometric methods for characterization of protein aggregation and antigen recognition structures

  2015cites this paper
• Conformational dynamics of α-synuclein: insights from mass spectrometry.

  2015cites this paper
• Ion Mobility—Mass Spectrometry-Based Screening for Inhibition of α-Synuclein Aggregation

  2015cites this paper
• Selection of RNA aptamers and their recognition of amyloid assemblies

  2015cites this paper
• Stabilization of Alpha-Synuclein Oligomers In Vitro by the Neurotransmitters, Dopamine and Norepinephrine: The Effect of Oxidized Catecholamines

  2015cites this paper
• Advances in ion mobility-mass spectrometry instrumentation and techniques for characterizing structural heterogeneity.

  2015cites this paper
• Identification and Affinity-Quantification of ß-Amyloid and α-Synuclein Polypeptides Using On-Line SAW-Biosensor-Mass Spectrometry

  2014influential citation
• Thioamide-Based Fluorescent Protease Sensors

  2014cites this paper
• Propagation of Oligomeric α-Synuclein and Amyloid-β: Implications for Parkinson's and Alzheimer's Diseases

  2014influential citation
• Parkinson's Disease: An Experimental Approach to Model the Visuo-Spatial Learning and Memory Deficits and an Analysis of Evidence Implicating α-Synuclein in Lewy Body Formation

  2014cites this paper
• Dopamine‐induced α‐synuclein oligomers show self‐ and cross‐propagation properties

  2014cites this paper
• Trifluoperazine rescues human dopaminergic cells from wild-type α-synuclein-induced toxicity.

  2014cites this paper
• Novel insights into protein misfolding diseases revealed by ion mobility-mass spectrometry.

  2013cites this paper
• Linking the structure of alpha-synuclein oligmers to function in Parkinson's disease

  2013cites this paper
• Mass spectrometry methods for intrinsically disordered proteins.

  2013cites this paper
• Advances in ion mobility spectrometry–mass spectrometry reveal key insights into amyloid assembly☆

  2013cites this paper
• Characterization of therapeutic antibodies and related products.

  2013cites this paper
• Applications and future of ion mobility mass spectrometry in structural biology

  2013cites this paper
• Characterization of oligomerization-aggregation products of neurodegenerative target proteins by ion mobility mass spectrometry.

  2012cites this paper